🖼

Fig. 3 — Relationship between cerebral small vessel disease and proteinopathies in the me

active
paper figure Created: 2026-04-21T18:29:40 By: paper_figures_tool Quality: 50% 🔗 External ID: paper-fig-55098313-7105-44ac-8daf-b540f6
Fig. 3 — Relationship between cerebral small vessel disease and proteinopathies in the me
Fig. 3Figure 3
Association between cerebral amyloid angiopathy (CAA) and proteinopathies. The plots visualize the association between CAA and Aβ-plaques, tau-tangles, and pTDP-43 in linear mixed effects models, that included CAA percentage area, age at death, and sex as fixed-factors and Braak-stage group, case, and region of interest as random-factors. CAA percentage area was positively associated with both Aβ plaques percentage area ( A ) and with density of tau-tangles ( B ). There was no significant association between CAA and density of phosphorylated-TAR-DNA-binding protein 43 (pTDP-43) cytoplasmatic inclusions ( C ). The models explained a large part of the variance of the dependent variable. Key: AM = amygdala; RC = rhinal cortex; Est. = estimate; HC = hippocampal body; PHC = posterior parahippocampal cortex
PubMed: 55098313-7105-44ac-8daf-b540f61c267e
Metadata
pmid55098313-7105-44ac-8daf-b540f61c267e
captionAssociation between cerebral amyloid angiopathy (CAA) and proteinopathies. The plots visualize the association between CAA and Aβ-plaques, tau-tangles, and pTDP-43 in linear mixed effects models, that
image_urlhttps://www.ebi.ac.uk/europepmc/articles/PMC12265290/bin/40478_2025_2076_Fig3_HTML.jpg
paper_titleRelationship between cerebral small vessel disease and proteinopathies in the medial temporal lobe.
figure_labelFig. 3
figure_number3
_schema_version1
source_strategypmc_api
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.